A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S T | U | V | W | X | Y | Z

Articles are indexed by drug names, trade names and disease terms. Bold entries refer to major references.

Key Word / Drug Name
Issue #: Page #

A

ABSSSI1:12; 2:7
acne scars5:2,3,5,6
acne2:7; 6:10
acute bacterial skin and skin structure infections1:12; 2:7
Aczone®6:10
adalimumab1:12; 2:8,9; 5:14
adjuvant therapy (melanoma)1:10-11; 2:7
aesthetic5:1-6
afamelanotide6:10
aging skin1:12; 2:8,10
Aklief®6:10
aluminum chloride1:1-3
androgenic alopecia5:1-6
anthraquinone3:7-9
antibiotic1:12; 2:7; 6:10
anticholinergic1:1-3; 2:1-3,8
antiperspirants1:1-3
antiviral2:8
apremilast5:14
ASN0022:10
atopic dermatitis2:4-6,8,10; 3:10; 5:14; 6:6,10
autologous fat grafting5:1,3,4,6
axillary hyperhidrosis1:1-7; 2:1-3

B

Behcet’s disease5:14
belimumab4:8
bempegaldesleukin5:14
Benlysta®4:8
betamethasone5:14
binimetinib2:7
biosimilar1:12; 2:8
biotin5:11
blistering3:7-9; 6:6
body contouring5:14
botulinum toxin1:3-4; 2:8,10
B-Raf proto-oncogene (BRAF)1:8-11; 2:7
brentuximab vedotin2:7
brodalumab2:9; 4:1-4
Bryhali™1:12; 2:9

C

calcipotriene5:14
camouflaging agents3:4
cellular grafting3:4
cemiplimab-rwlc2:7
certolizumab pegol2:9
checkpoint inhibitor1:8-11; 2:7,8,9
chronic urticaria6:5-6
combination immunotherapy1:10
CoolTone™5:14
corticosteroid4:8; 5:14
Cosentyx®2:9
crisaborole2:4-6,8
CSCC2:7
CTCL2:7,8
CTLA-41:8-11
cutaneous lupus erythematosus6:6
cutaneous sarcoidosis6:6
cutaneous squamous cell carcinoma2:7
cutaneous T-cell lymphoma2:7
cytotoxic T-lymphocyte-associated protein 41:8-11

D

dabrafenib2:7
delafloxacin1:12; 2:7
dapsone6:10
depigmentation therapies3:4-5
dermal filler1:12; 2:8; 5:5-6; 6:10
diacerein3:7-9
DRM041:1-3; 2:1-3
drug interactions6:7
Duobrii™4:8
dupilumab3:10; 5:14
Dupixent®3:10; 5:14

E

eczema2:4-6,8,10; 3:10; 5:14; 6:6,10
Enbrel®4:8
encorafenib2:7
Enstilar®5:14
eon™ FR5:14
epidermolysis bullosa simplex3:7-9
erythropoietic protoporphyria (EPP)6:10
etanercept4:8
Eticovo™4:8
Eucrisa®2:4-6,8

F

Fabry disease2:8
facial rejuvenation5:1-3,5-6
fat injections5:3-6
focused ultrasound1:3-5
fractional laser resurfacing5:2-3,5

G

Galafold™2:8
Gardasil®92:8
glycopyrronium tosylate1:1-3; 2:1-3,8
graft-versus-host disease (GVHD)4:8
granulomatosis with polyangiitis (GPA)6:10
guselkumab3:10

H

Hadlima™2:8,9; 5:14
hair restoration5:1-4
hair5:7-13
halobetasol propionate1:12; 2:9; 4:8
hepatotoxicity6:6-7
hereditary angioedema2:8
herpes zoster3:5-7
hidradenitis suppurativa2:8,9
human papillomavirus (HPV)2:8
Humira®1:12; 2:8,9; 5:14
hyaluronic acid dermal filler1:12; 2:8; 6:10
hyperhidrosis1:1-7; 2:1-3,8
Hyrimoz™1:12; 2:9

I

Ilumya™1:12; 2:9; 6:1-4
immunotherapy1:8-11; 2:10
interleukin-13 (IL-13)3:10
interleukin-17 (IL-17)2:9; 4:1-4
interleukin-23 (IL-23)1:12; 2:9; 3:10; 4:8; 6:1-4
interleukin-4 (IL-4)3:10
iontophoresis1:2-4
ipilimumab1:8-11; 2:7
ixekizumab2:9

J

Jakafi®4:8
Janus kinase (JAK) inhibitors4:8
Jeuveau™2:10
Juvederm®6:10
Jynneos™6:10

K

Keytruda®1:8-11,12; 2:8,10; 3:10

L

lanadelumab-flyo2:8
laser therapy1:3-5; 5:2-3,5; 5:14
lidocaine2:9,10
localized scleroderma6:6
lupus4:8; 6:6

M

magnetic muscle stimulation5:14
MEK inhibitor1:8-11; 2:7; 4:8
Mekinist®2:7
melanocortin 1 receptor (MC1R)6:10
melanoma1:8-11; 2:7; 3:10; 5:14
melatonin5:11
mental health4:1-4
merkel cell carcinoma1:12; 2:8,10
methicillin resistant Staphylococcus aureus1:12
methotrexate6:5-8
microneedling5:2-3,5
microwave thermolysis1:3-4
migalastat2:8
mitogen-activated protein kinase
kinase inhibitor1:8-11; 2:7
mogamulizumab-kpkc2:8
monoclonal antibody1:12; 2:8,9; 3:10; 6:1-4
MRSA1:12
mycosis fungoides2:8; 6:6

N

nail5:7-11
neurofibromatosis4:8
niacinamide5:11
nivolumab1:8-11; 5:14
NKTR-2145:14
Nuceiva®2:8
Nuzyra™1:12; 2:7

O

omadacycline1:12; 2:7
Opdivo®1:8-11; 5:14
Otezla®5:12

P

PD-03259014:8
pembrolizumab1:8-11,12; 2:8,10; 3:10
pemphigus vulgaris2:8
phosphodiesterase-4 inhibitor (PDE-4)2:4-6,8; 5:14
phototherapy3:3
phototoxicity6:10
platelet-rich plasma (PRP)5:1-6
Pliaglis®2:10
post-herpetic neuralgia (PHN)2:9; 4:5
Poteligeo®2:8
PPIES5:7-13
prabotulinumtoxinA2:8,10
prebiotics5:11
probiotics5:11
programmed cell death-ligand 1 (PD-L1)1:8-11; 2:7,8,10; 3:10; 5:14
protein replacement therapy (PTR-01)4:8
psoriasis1:12; 2:8,9; 3:10; 4:8; 5:14; 6:1-4,5
psoriatic arthritis1:12; 2:8,9; 4:8

Q

Qbrexza1:1-3; 2:1-3,8

R

rash4:5-7
recessive dystrophic epidermolysis bullosa4:8
recombinant subunit vaccine4:5-7
Restylane® Lyft1:12; 2:8
retinoic acid receptor6:10
retinoid4:8; 6:10
rhein prodrug3:7-9
rhytids5:1-3,5-6
risankizumab3:10; 4:8
Rituxan®2:8; 6:10
rituximab2:8; 6:10
ruxolitinib4:8

S

sarcoidosis6:6
sarecycline hydrochloride2:7
scalp psoriasis2:9
scars5:1-3,5
Scenesse®6:10
scleroderma6:6
secukinumab2:9
Sézary syndrome2:8
shingles2:9; 4:5-7
Shingrix®4:5-7
Siliq™2:9; 4:1-4
Skyrizi™3:10; 4:8
smallpox2:8; 6:10
striae distensae5:3,6
suicidal ideation4:1-4
supplements5:7-11
sweat1:1-7; 2:1-3,8
sympathectomy1:3-6
synbiotics5:11
systemic lupus erythematosus4:8

T

Taclonex®5:14
Tafinlar®2:7
Takhzyro™2:8
Talz®2:9
tazarotene4:8
tecovirimat2:8
tetracaine2:10
thermolysis1:3-4
tildrakizumab1:12; 2:9; 6:1-4
tissue grafting techniques3:3-4
trametinib2:7
Tremfya®3:10
tretinoin2:7
trifarotene6:10

U

ultrasound1:3-5

V

vaccine2:8; 4:5-7
varicella zoster virus4:5-7
vasculitis6:10
vitamin D5:11,14
vitiligo3:1-6
Voluma®6:10

W

Wegener’s granulomatosis6:10

X

Xydalba™1:12; 2:7

Y

Yervoy®1:8-11; 2:7

Z

ZTlido™2:9

Purchase Article PDF for $1.99